My grandmother fractured her hip at 78. The fall itself was barely a fall — she tripped on a rug edge stepping out of the shower. The fracture was the kind of thing that, in a 30-year-old, would have been a bruise. In her, it was four months of recovery, two surgeries, and the kind of slow decline that happens when a body that was already losing bone density loses the ability to walk briskly through the world.
I think about that fall every time someone in their 30s or 40s asks me whether they "should be worrying about bones yet." The honest answer is: the bone density you carry into your 60s is built in your 30s and 40s. By the time the DEXA scan tells you there's a problem, you've already lost ground that's expensive to get back.
This article is about the specific vitamin pairing that the bone-health literature keeps coming back to: vitamin D3 with vitamin K2. They're not the same nutrient. They don't do the same thing. And they don't do their best work without each other. I run a sublingual strip company that ships a D3 + K2 strip, so I have skin in this game — but the science behind why these two belong together is older and bigger than my product.
The two vitamins, in plain language
Vitamin D3 (cholecalciferol) is the fat-soluble vitamin your skin makes when sunlight hits it. The NIH Office of Dietary Supplements describes its primary role as regulating calcium homeostasis — when D3 levels are adequate, your gut absorbs more calcium from food, and your kidneys reclaim more of it from filtrate. Inadequate D3 leaves you absorbing a fraction of dietary calcium regardless of how much you eat.
Vitamin K2 (menaquinone) is a fat-soluble vitamin most people have never heard of. It's structurally related to vitamin K1 (the one in leafy greens that the liver uses for blood clotting), but K2 has different work to do. Its job is to activate two specific proteins — osteocalcin and matrix Gla-protein — that direct where calcium ends up in the body.
Read that last line again. The job isn't "more calcium." The job is directing where calcium goes.
The pathway, drawn out
Here's the simplified version of the bone-calcium pathway, the way it shows up in standard nutrition pharmacology texts:
- You eat calcium. Dairy, leafy greens, fortified foods, a supplement — doesn't matter where it comes from.
- Vitamin D3 helps you absorb it. Without adequate D3, your gut pulls in a small fraction of dietary calcium. With adequate D3, that fraction roughly doubles.
- The absorbed calcium enters your bloodstream. Now it's circulating — but circulating calcium doesn't automatically become bone. It can deposit in bone. It can also deposit in soft tissue (arteries, kidneys), where you don't want it.
- Vitamin K2 activates osteocalcin. Osteocalcin is the protein that binds circulating calcium and pulls it into the bone matrix. Without K2, osteocalcin sits inactive — and the calcium your D3 helped you absorb has fewer instructions about where to go.
- Vitamin K2 also activates matrix Gla-protein (MGP). MGP is the protein that prevents calcium from depositing in arterial walls. Without K2, MGP sits inactive, and circulating calcium has a higher chance of ending up where it shouldn't.
The pairing isn't a wellness trend. It's a pathway. D3 brings calcium in. K2 tells it where to settle. Without both, you've supplied a raw material with no instructions.
What the research actually shows
Peer-reviewed work on K2 and bone density goes back decades. A few of the studies the bone-health literature most often cites:
The Rotterdam Study, a large prospective cohort, found that higher dietary K2 intake was associated with lower arterial calcification and lower cardiovascular mortality. Geleijnse et al. (Journal of Nutrition, 2004) reported the dose-response across thousands of participants.
The Maastricht Osteoporosis trials, conducted in postmenopausal women, found that supplemental K2 (MK-7 form, 180 mcg/day for 3 years) significantly reduced age-related loss of bone mineral density at the lumbar spine and femoral neck, compared to placebo. Knapen et al. (Osteoporosis International, 2013).
The NIH Office of Dietary Supplements Vitamin D Fact Sheet explicitly states that vitamin D supplementation increases calcium absorption — and that the calcium has to come from somewhere (diet or supplementation) for D3 to have a bone-density effect.
None of these studies, taken alone, "prove" that D3 + K2 prevents fractures in healthy adults. The honest framing is: the mechanism is well-established, the pathway is well-mapped, and the observational and trial data are consistent with a bone-density support role. Not a treatment for osteoporosis. Not a fracture-prevention guarantee. A nutritional pairing that supports a pathway your body needs to work.
Why MK-7 specifically, and not MK-4
If you start reading K2 supplement labels, you'll see two forms: MK-4 and MK-7. They are not equivalent.
MK-4 is the short-chain form. Half-life in blood is roughly an hour. To maintain steady tissue levels with MK-4, you have to dose multiple times a day at high doses (typically 15 mg, three times daily, in the Japanese clinical trials where MK-4 was studied for bone outcomes).
MK-7 is the long-chain form, derived from natto (fermented soybeans). Half-life in blood is roughly 72 hours — about 70 times longer than MK-4. A 100–200 mcg daily dose maintains steady tissue levels in most adults, per the pharmacokinetic work in the Maastricht trials.
For a daily supplement format, MK-7 is the practical choice. The dose fits in a strip or a small capsule, the half-life supports once-daily use, and the trial data on bone density specifically used MK-7 at this dose range.
If a "K2" supplement doesn't specify the form on the label, default to skeptical. If it specifies MK-4 at a low daily dose, default to skeptical — that dose probably doesn't maintain tissue levels.
The dose ranges that actually work
From the published literature, the dose ranges associated with bone-density support in adults:
- Vitamin D3: 1,000–4,000 IU/day for most adults, with the upper end appropriate when serum 25-hydroxyvitamin D is below the optimal range (typically <30 ng/mL). The NIH RDA is 600–800 IU, but the bone-density trial literature generally used the higher end of 1,000–2,000 IU.
- Vitamin K2 (MK-7): 90–200 mcg/day. The Maastricht trials used 180 mcg. Below 50 mcg/day, the effect on osteocalcin activation appears minimal in the published data.
If you're on a blood thinner (especially warfarin), K2 supplementation can interact with anticoagulation and should be discussed with the prescribing physician before starting. This isn't a "warning" written for legal cover — warfarin's mechanism is specifically vitamin-K antagonism, and adding K2 can meaningfully change the INR.
When other interventions matter more
I'd lose credibility if I pretended D3 + K2 alone solved bone health. The bone-density picture is bigger than two vitamins. The interventions with the strongest fracture-prevention evidence in older adults are:
- Weight-bearing exercise. Resistance training and impact-loading exercise consistently appear in the strongest tier of bone-density evidence. The body literally builds bone in response to mechanical load.
- Adequate dietary calcium. D3 helps you absorb calcium, but it has to come from somewhere. 1,000–1,200 mg/day from diet is the typical recommendation in the bone-health guidelines.
- Adequate protein. Bone is roughly half protein by volume. Older adults with inadequate protein intake lose bone faster regardless of vitamin status.
- Not smoking. Smoking is a clear independent risk factor for accelerated bone loss.
- Moderate alcohol. Heavy alcohol use is associated with reduced bone formation.
- Bone-density medications when indicated. For diagnosed osteoporosis, bisphosphonates and other prescription medications have stronger fracture-prevention evidence than any vitamin pairing.
If you're in your 70s and have diagnosed osteoporosis, vitamins are a supporting cast member, not the lead. Talk to your doctor. If you're in your 30s building the bone density you'll carry into your 60s, the pairing matters at the margin — alongside the lifestyle factors that matter at the foundation.
Why we built the XYNE Bone Support strip
The XYNE Bone Support strip pairs D3 and MK-7 K2 in a single daily sublingual dose, plus a small amount of complementary minerals. The reason it's a strip and not a capsule is partly format-preference and partly pharmacokinetic: both D3 and K2 are fat-soluble, both absorb well sublingually, and both fit within the per-strip dose ceiling at the dose ranges supported by the trial literature.
What the strip doesn't try to be: a high-dose calcium product. Calcium's required dose (500–1,200 mg/day) doesn't fit in a film, and calcium absorbs better with food and stomach acid than under the tongue. If you need more calcium, that's a different format — a capsule, fortified food, or dietary change. The strip handles the D3 + K2 pairing. You handle the calcium and the gym.
Founder's compulsion, not a marketing line: this is the formulation I wanted my mom on. The pairing the bone-density literature keeps pointing at, in a dose range supported by the trial data, in a format she'd actually take consistently.
Frequently asked questions
Can I just take D3 alone if I don't eat fermented foods?
You can, and many people do. But the pathway argument is that D3 brings calcium into the bloodstream, and K2 activates the proteins that direct where it settles. The Rotterdam and Maastricht data suggest the pairing has a different long-term picture than D3 alone. The honest answer: D3 alone is better than neither; D3 + K2 is what the pathway literature points at.
Is sublingual delivery actually better for D3 and K2 specifically?
The bioavailability difference between oral and sublingual D3 is small — the gut handles fat-soluble vitamins well. The reason to use a strip is format preference (no pill, no aftertaste, no water needed) more than an absorption argument. K2 similarly absorbs well via both routes. The strip's argument here is compliance and convenience, not a 23× absorption multiplier.
How long until D3 + K2 supplementation shows up on a DEXA scan?
The bone-density trials run 2–3 years to detect a measurable change in DEXA-assessed bone mineral density. Bone remodels slowly. You won't see a difference in a month. The framing is "supporting a long pathway," not "fixing a number."
Is it safe to take K2 with a blood thinner?
Not without a conversation with your prescriber. Warfarin's mechanism is specifically vitamin-K antagonism — adding K2 can shift the INR. Direct oral anticoagulants (apixaban, rivaroxaban, etc.) work through a different mechanism and aren't affected the same way, but any change in supplement routine should be discussed with the prescribing physician.
What's the difference between K1 from greens and K2 from supplements?
K1 and K2 are related but not interchangeable. K1 (phylloquinone) is the form in leafy greens; the liver uses most of it for blood clotting. K2 (menaquinones, including MK-4 and MK-7) is the form active in bone and arterial tissue. A diet high in greens doesn't reliably produce high K2 status, because the conversion from K1 to K2 in the gut is modest and inconsistent.
D3 + K2 isn't a fracture cure. It's a pairing that supports a pathway the bone-density literature keeps pointing at. For the people in their 30s and 40s building the bone they'll carry forward, the pairing belongs in the conversation. For the people already managing osteoporosis, it belongs alongside medical treatment, not instead of it.
If you want a recommendation tailored to your routine, take the quiz. If you want to browse, the lineup is here. And for the format-mechanism background, here's the pharmacokinetics piece.
Related reading
- Oral Strips vs Pills: Which Format Wins for Which Nutrient — Per-nutrient decision frame, including where fat-soluble vitamins land.
- Sublingual vs Oral Supplements: Where Your Ingredients Actually Go — The pharmacokinetics piece on the four-stop oral journey vs the one-stop sublingual route.
- Bioavailability Explained: Why Format Determines What You Absorb — The plain-spoken version of how dose-on-label and dose-in-blood diverge.
- Vegan, Halal, and Allergen-Free Supplements — Including what "vegan K2" actually means on a label.
